CHEK1 and neuroblastoma: In this project, we demonstrated that the novel pan-HDACI, panobinostat [14], substantially repressed the expression of CHK1 leading to abrogation of the G2 cell cycle checkpoint and synergistically enhanced the cytotoxic effects of etoposide, doxorubicin, or cisplatin, on high-risk neuroblastoma cells.